C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2004
12/02/2004	WO2004103309A2 Immunosuppressant compounds and compositions
12/02/2004	WO2004103306A2 Immunosuppressant compounds and compositions
12/02/2004	WO2004103289A2 Driverse thyroid hormone receptor antagonists and uses thereof
12/02/2004	WO2004076413A3 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
12/02/2004	WO2004072031A3 Phenylacetamides and their use as glucokinase modulators
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242915 Aluminum catalyst impregnated with metal hydroxide; used for forming blocking agents for amines, alcohols, mercaptans
12/02/2004	US20040242888 Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative
12/02/2004	US20040242887 Hypotonic bladder diseases
12/02/2004	US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant
12/02/2004	US20040242648 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
12/02/2004	US20040242639 Compounds such as 4-[4-(2-methoxyphenyl)-1-piperazinyl]-3-[[(phenylamino)carbonyl]amino]-benzamide, for therapy of restenosis
12/02/2004	US20040242609 Therapy for eating disorders, sexual disorders, psychological disorders
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242539 Method of enhancing lysosomal alpha-galactosidase A
12/02/2004	DE10320326A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis
12/02/2004	CA2525501A1 Tetrahydroisoquinoline derivatives as ppar-.alpha. activators
12/02/2004	CA2524047A1 Immunosuppressant compounds and compositions
12/01/2004	EP1481970A1 Novel herbicides
12/01/2004	EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1481966A1 Novel arylamidine derivative or salt thereof
12/01/2004	EP1481673A1 Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist
12/01/2004	EP1480963A1 Method for producing 3-amidinophenylalanine derivatives
12/01/2004	EP1480952A2 Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine
12/01/2004	EP1359891A4 Primary intermediates for oxidative coloration of hair
12/01/2004	EP1351921B1 Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds
12/01/2004	EP1196383B1 Process for preparing amlodipine benzenesulphonate
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825043 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
11/25/2004	WO2004101546A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/25/2004	WO2004101523A1 Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
11/25/2004	WO2004101522A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	WO2004101521A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	WO2004101520A1 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists
11/25/2004	WO2004101519A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	WO2004101518A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	WO2004101507A2 N-sulphonylated amino acid derivatives and use thereof as matriptase inhibitors
11/25/2004	WO2004100960A2 Anti-inflammatory phosphonate compounds
11/25/2004	WO2004100952A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opioid receptors ligands
11/25/2004	WO2004085385A3 Cannabinoid receptor ligands
11/25/2004	WO2004080959A3 Process for the preparation of dexmethylphenidate hydrochloride
11/25/2004	WO2004064738A3 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
11/25/2004	WO2004043379A3 Chemical compounds
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235910 Mutilin derivatives and their use as antibacterials
11/25/2004	US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004	US20040235897 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235895 hydrogenation of 4-hydroxypiperidine and 1-tert-butoxycarbonyl-4-piperidone in the presence of catalysts, then coupling the reaction product with 3,4-dichlorofluorobenzene, to form 4-(3,4-dichlorophenoxy)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester; ctalysis; chemical intemeadiates
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235893 Methods for the stereoselective synthesis of substituted piperidines
11/25/2004	US20040235832 Sexual diosrders; schizophrenia; drug abuse; eating disorders anxiolytic agents
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235828 For therapy and prophylaxis of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, migraine, tumours, tumour diseases and/or tumour metastases
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235666 Substituted imidates as pesticidal agents
11/25/2004	CA2525886A1 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors
11/25/2004	CA2525860A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	CA2525858A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
11/25/2004	CA2525849A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	CA2523431A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/24/2004	EP1479666A1 Ester compound and medicinal use thereof
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1478359A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	EP1200406B1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor
11/24/2004	EP1076055B1 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	CN1549718A Use of compounds for treating conditions resulting from injury to the corneal nerve after LASIK and other ocular surgeries
11/24/2004	CN1549715A Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders
11/23/2004	US6822099 Method of resolving amlodipine racemate
11/23/2004	US6821998 Arylamines as inhibitors of chemokine binding to US28
11/23/2004	US6821985 Administering an nr2b subtype selective n-methyl-d-aspartate (nmda) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	US6821963 4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
11/23/2004	US6821396 Process for fractionating water-containing crude amine mixtures from amine synthesis
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099144A1 Chemical compounds
11/18/2004	WO2004099143A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them
11/18/2004	WO2004099142A1 Hydrobromide salt of benzyl-piperidylmethyl-indanone and its polymorphs
11/18/2004	WO2004087700A8 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
11/18/2004	WO2004074246A3 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/18/2004	US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229924 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/TACE inhibitors
11/18/2004	US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication

1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 380